Clinical Trial Update: Nefiracetam in the Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of nefiracetam for Alzheimer's disease has completed. The study was sponsored by the National Institute of Neurological Disorders and Str…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nefiracetam (nefiracetam)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED